Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder

Phase 3 Completed 244 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

RandomizedParallel-groupDouble-blindTreatment

Summary

The main objective of this study is to compare the antidepressant efficacy and safety of DVS-233 SR versus placebo in adult outpatients with Major Depressive Disorder.

Timeline

Start: —
Primary completion: 2005-05
Completion: 2005-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DVS-233 SR	Unknown	—	—

Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder

Summary

Timeline

Drugs

Indications